Same Indication

Pravastatin vs Tofacitinib

Pravastatin vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Pravastatin and Tofacitinib.

Mechanism of Action

Pravastatin: Competitive inhibitor of HMG-CoA reductase.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Pravastatin β€” 1.8 hours; Tofacitinib β€” 3.2 hours.

Chemical Properties

Molecular Formula: Pravastatin β€” C23H36O7; Tofacitinib β€” C16H20N6O.

Molecular Weight: Pravastatin β€” 424.5280 g/mol; Tofacitinib β€” 312.3700 g/mol.

Type: Pravastatin β€” Small molecule; Tofacitinib β€” Small molecule.